A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting

BACKGROUND: The introduction of human epidermal growth factor receptor 2 (HER2)-targeted treatment options, including dual HER2 blockade, has improved the prognosis for patients with HER2-positive breast cancer (BC) substantially. However, most of these treatments are administered via the intravenou...

Descripción completa

Detalles Bibliográficos
Autores principales: McCloskey, Conor, Ortega, María Toboso, Nair, Sunita, Garcia, Maria João, Manevy, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395845/
https://www.ncbi.nlm.nih.gov/pubmed/35996066
http://dx.doi.org/10.1007/s41669-022-00361-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395845/
https://www.ncbi.nlm.nih.gov/pubmed/35996066
http://dx.doi.org/10.1007/s41669-022-00361-3

Ejemplares similares